sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C33H36ClN6NaO10S2 — CID 172958257

IUPACsodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SMILESC[C@@H]1S[C@@H]2[C@H](CC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3csc(N)n3)C(=O)N2C(C(=O)[O-])=C1C[N+]12CCC[C@H]1CN(C(=O)c1cc(O)c(O)c(Cl)c1)CC2.[Na+]
InChIInChI=1S/C33H37ClN6O10S2.Na/c1-15-19(13-40-7-4-5-17(40)12-38(6-8-40)27(44)16-9-20(34)26(43)23(42)10-16)25(30(46)47)39-28(45)18(29(39)52-15)11-22(41)24(21-14-51-32(35)36-21)37-50-33(2,3)31(48)49;/h9-10,14-15,17-18,29H,4-8,11-13H2,1-3H3,(H5-,35,36,37,41,42,43,44,46,47,48,49);/q;+1/p-1/t15-,17-,18+,29+,40?;/m0./s1
InChIKeySLFPSOOVBFTJIW-KMCJRBSKSA-M
MW799.26 g/mol
LogP-2.94
Rot. Bonds11

About sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (PubChem CID 172958257) has the molecular formula C33H36ClN6NaO10S2 and a molecular weight of 799.26 g/mol. Its IUPAC name is sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate.

Molecular Properties

Compound Namesodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
PubChem CID172958257
Molecular FormulaC33H36ClN6NaO10S2
Molecular Weight799.26 g/mol
Exact Mass798.15
IUPAC Namesodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SMILESC[C@@H]1S[C@@H]2[C@H](CC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3csc(N)n3)C(=O)N2C(C(=O)[O-])=C1C[N+]12CCC[C@H]1CN(C(=O)c1cc(O)c(O)c(Cl)c1)CC2.[Na+]
InChIInChI=1S/C33H37ClN6O10S2.Na/c1-15-19(13-40-7-4-5-17(40)12-38(6-8-40)27(44)16-9-20(34)26(43)23(42)10-16)25(30(46)47)39-28(45)18(29(39)52-15)11-22(41)24(21-14-51-32(35)36-21)37-50-33(2,3)31(48)49;/h9-10,14-15,17-18,29H,4-8,11-13H2,1-3H3,(H5-,35,36,37,41,42,43,44,46,47,48,49);/q;+1/p-1/t15-,17-,18+,29+,40?;/m0./s1
InChIKeySLFPSOOVBFTJIW-KMCJRBSKSA-M
XLogP-2.94
TPSA238.91 Ų
H-Bond Donors3
H-Bond Acceptors15
Rotatable Bonds11
Heavy Atoms53
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500799.26
LogP ≤ 5-2.94
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_one_A(321)', 'substructure': 'N/A'}, {'alert_name': 'catechol_A(92)', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate?
The IUPAC name of sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (CID 172958257) is sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate.
What is the SMILES notation for sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate?
The canonical SMILES for sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate is C[C@@H]1S[C@@H]2[C@H](CC(=O)/C(=N\OC(C)(C)C(=O)[O-])c3csc(N)n3)C(=O)N2C(C(=O)[O-])=C1C[N+]12CCC[C@H]1CN(C(=O)c1cc(O)c(O)c(Cl)c1)CC2.[Na+].
What is the InChIKey of sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate?
The InChIKey is SLFPSOOVBFTJIW-KMCJRBSKSA-M. The full InChI is InChI=1S/C33H37ClN6O10S2.Na/c1-15-19(13-40-7-4-5-17(40)12-38(6-8-40)27(44)16-9-20(34)26(43)23(42)10-16)25(30(46)47)39-28(45)18(29(39)52-15)11-22(41)24(21-14-51-32(35)36-21)37-50-33(2,3)31(48)49;/h9-10,14-15,17-18,29H,4-8,11-13H2,1-3H3,(H5-,35,36,37,41,42,43,44,46,47,48,49);/q;+1/p-1/t15-,17-,18+,29+,40?;/m0./s1.
What are the key properties of sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate?
sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate has a molecular weight of 799.26 g/mol, XLogP of -2.94, 11 rotatable bonds, 3 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for sodium (4S,6R,7R)-3-[[(8aS)-2-(3-chloro-4,5-dihydroxybenzoyl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-5-ium-5-yl]methyl]-7-[(3Z)-3-(2-amino-1,3-thiazol-4-yl)-3-(2-carboxylatopropan-2-yloxyimino)-2-oxopropyl]-4-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate is sourced from PubChem (CID 172958257), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).